Investment Rating - The investment rating for the company is "Outperform the Market" [1][5] Core Views - The company is expected to achieve a revenue of 9.1 to 9.2 billion with a year-on-year growth of 34.0% to 35.4%, and a net profit of 1.14 to 1.16 billion, reflecting a year-on-year increase of 41.9% to 44.4% for 2025 [2][3] - The successful implementation of a multi-brand and multi-category strategy has allowed the main brand, Han Shu, to solidify its skincare foundation while expanding into makeup and men's products. The new baby skincare brand, Newpage, has also seen significant revenue growth, creating a second growth curve with high certainty [2][8] - The company's growth certainty and profit resilience are significantly better than the industry average, supported by continuous optimization of channel structure and breakthroughs in R&D [2][8] Financial Forecasts - The projected net profit for 2025-2027 is 1.107 billion, 1.388 billion, and 1.702 billion respectively, with corresponding P/E ratios of 20, 16, and 13 [2][8] - For the second half of 2025, revenue is expected to be between 4.99 to 5.09 billion, with a year-on-year growth of 51.7% to 54.8%, and a net profit of 580 to 600 million, reflecting a year-on-year increase of 49.5% to 54.6% [3][8] - The net profit margin for 2025 is estimated to be around 12.5% to 12.6%, an increase of approximately 0.7% to 0.8% compared to 2024 [3]

Core Insights - The article discusses the brand "造物者" (Creator) and its recent brand upgrade, focusing on the release of the TVC "To Female Creators," which emphasizes the theme of "freedom" and the importance of self-identity for women in various roles [3][4][5][7]. Brand Evolution - The Chinese cosmetics market is projected to exceed 1.1 trillion yuan by 2025, with domestic brands capturing 57.37% market share, indicating a shift from basic quality assurance to deeper brand building [4]. - "造物者" is transitioning from establishing "quality trust" to achieving "value resonance," reflecting a more profound engagement with consumers [4]. Concept of "Freedom" - The TVC portrays "freedom" as a state of being where women can focus on their true selves without external pressures, addressing the common struggle of role overload faced by modern women [5][7]. - The narrative suggests that by prioritizing personal well-being and self-awareness, women can reclaim their inner strength and creativity [7]. Brand Positioning - "造物者" aims to be a companion for women rather than instructing them on how to become creators, providing products that facilitate moments of self-return and relaxation [9][11]. - The brand's new philosophy emphasizes that every woman has the power to shape her life, regardless of her role, and seeks to respond to their needs through meaningful engagement [12][18]. Product Innovation - The brand has focused on the soft film category, enhancing user experience through scientific advancements and extensive research, establishing itself as a leader in this niche [13][16]. - The unique "15-minute skincare" process is designed not only for efficacy but also as a moment of self-care, allowing women to enjoy a brief escape from their busy lives [16][18]. Market Impact - In 2025, "造物者" achieved significant milestones, including being recognized as the top seller in the soft film category and serving over 3 million users, demonstrating the brand's alignment with market demands [18]. - The article highlights a shift in female marketing strategies, moving from defining beauty standards to recognizing and supporting women's authentic experiences [20][22]. Future Directions - "造物者" plans to continue evolving its brand identity by expanding product lines, enhancing visual representation, and creating immersive experiences that resonate with women's needs [22][24]. - The brand's approach signifies a fundamental shift from being a "gazer" to a "companion," fostering deeper emotional connections with consumers [22][24].

Group 1 - China Coal Australia (03668.HK) maintains a "Buy" rating with a target price of HKD 38, benefiting from rising natural gas prices due to Middle East geopolitical conflicts, which may drive coal prices up, enhancing profitability by 5% for every 1% increase in coal prices [1] - Aubo Holdings (00880.HK) holds a "Neutral" rating with a target price of HKD 2.20, facing short-term market share pressure and a 3% decline in EBITDA margin due to the closure of satellite entertainment venues, but is working on property upgrades to attract customers [1] - Neway Group (01686.HK) is upgraded to a "Buy" rating with a target price of HKD 8.58, as its MEGA IDC phase one has a 91% occupancy rate, and demand for AI reasoning and high-density deployment is significantly increasing [1] Group 2 - JD Group (09618.HK) receives a "Strong Buy" rating, with Q4 retail operating profit down only 2.5% year-on-year, better than expected, and a recovery in food delivery losses, alongside double-digit growth in daily necessities and 3P advertising revenue [2] - JD Logistics (02618.HK) maintains a "Buy" rating, with Q4 non-IFRS net profit up 5.7%, driven by significant internal revenue growth of 68% from instant delivery, and the privatization of Debon is expected to accelerate network integration and profitability recovery [2] Group 3 - China Tobacco Hong Kong (06055.HK) holds a "Buy" rating, with a projected 14.8% year-on-year growth in net profit for 2025, and a 6.2 percentage point increase in H2 cigarette export gross margin to 21.4%, attributed to channel expansion and product optimization [3] Group 4 - Bilibili-W (09626.HK) maintains a "Buy" rating, with Q4 DAU up 10% to 113 million, and advertising revenue increasing by 27%, driven by improved ad efficiency and AIGC tool applications, achieving annual profitability for the first time [4] Group 5 - Bosideng (03998.HK) holds a "Buy" rating, achieving mid-single-digit revenue growth despite a warm winter, with brand strength reinforced through designer series and successful international expansion [5] Group 6 - Swire Properties (01972.HK) maintains a "Buy" rating, with 67% completion of its HKD 100 billion investment plan, and a projected 9% CAGR for mainland IP rights area by 2032, showcasing strong financial health and stable dividend growth [6] Group 7 - Shangmei Co. (02145.HK) holds a "Buy" rating, with projected revenue growth of 34.0%-35.4% and net profit growth of 41.9%-44.4% for 2025, driven by strong sales of popular product lines and healthy channel structure [7]

Macro Insights - February non-farm payroll data fell short of expectations, influenced by temporary disruptions from healthcare sector strikes and weather factors, with potential risks of further deterioration in employment data due to escalating Middle East tensions and rising oil prices [1] - The 2026 government work report emphasizes a pragmatic and long-term policy approach, focusing on consumption and technology as the main structural drivers for the capital market [2][3] Industry Research - The machinery manufacturing sector is expected to see a sustained recovery in demand driven by equipment upgrades, exports, and the electrification and automation of machinery, with significant opportunities in the fusion and low-altitude economy industries [9] - The refrigerant industry is projected to maintain high demand due to supply constraints from quota policies and steady growth in downstream applications like air conditioning and refrigeration [10] - The real estate sector is focusing on stabilizing the market with differentiated policies based on local conditions, which is expected to improve market expectations [11] Company Research - Xingfu Electronics, a leader in electronic-grade phosphoric acid, is expected to see significant profit growth from 2025 to 2027, driven by its strategic partnerships and technological advantages [12] - Yake Technology is benefiting from the high demand for storage chips and is projected to maintain strong profit growth through 2027, supported by its unique semiconductor materials and LNG composite technology [13] - China National Offshore Oil Corporation (CNOOC) is positioned to benefit from rising oil prices due to geopolitical tensions, with a focus on energy security and a dual approach to oil and gas production [14] - Bilibili is experiencing growth in its advertising business driven by AI technology, with adjusted profit forecasts for 2026 and 2027 reflecting a strategic focus on AI investments [15] - Shangmei Co. is expected to achieve significant revenue growth in 2025, supported by its multi-brand strategy and strong performance in various product categories [16] - Yanjinpuzi is leveraging its organizational restructuring to enhance product strategies and is expected to benefit from new product launches and cost reductions in 2026 [17]

Group 1: Economic and Market Overview - The Middle East situation has led to a surge in global oil prices, impacting supply chains and inflation expectations in the U.S. [10][11] - A 10% increase in oil prices is estimated to raise the overall U.S. CPI by 24-28 basis points and core CPI by 4-7 basis points [11][12] - The closure of the Strait of Hormuz could potentially push oil prices up to $140 per barrel, affecting inflation dynamics [11][12] Group 2: Taikoo Properties (01972) Analysis - Taikoo Properties is focusing on a significant investment plan, targeting a 9% CAGR in IP area in mainland China from 2026 to 2032 [14] - The company has a strong asset management capability and aims to enhance its dividend growth steadily [14] - The business structure includes a significant portion of revenue from IP, with a focus on high-end commercial properties in Hong Kong and mainland China [14][12] Group 3: Dongyangguang (600673) Insights - Dongyangguang has acquired 100% control of Qinhuai Data, a leading IDC company, which will enhance its capabilities in data center operations [13][17] - The company plans to expand its capacity to 4GW, focusing on green energy and collaborative synergies with Qinhuai Data [17] - Financial performance shows a revenue increase of 5.52% year-on-year, with a net profit margin of 25.93% [13]

Group 1 - The core viewpoint of the article is that the company, Up Beauty Co., is expected to achieve impressive financial performance in 2025, with significant revenue and profit growth driven by its multi-brand and multi-category strategy [4][5] Group 2 - In 2025, the company anticipates revenue between 9.1 billion to 9.2 billion yuan, representing a year-on-year increase of 34.0% to 35.4%, and a net profit of 1.14 billion to 1.16 billion yuan, reflecting a year-on-year increase of 41.9% to 44.4% [4] - For the first half of 2025, the company expects to achieve revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, a year-on-year increase of 34.7% [4] - In the second half of 2025, the company projects revenue of 5.04 billion yuan, a year-on-year increase of 53.2%, and a net profit of 590 million yuan, a year-on-year increase of 52.1% [4] Group 3 - The company's strong performance is attributed to the successful layout of multiple brands and categories, with notable growth in the scientific anti-aging skincare brand Han Shu and the infant and child skincare brand Newpage [5] - According to third-party platform data, Han Shu's sales on Taobao and Douyin increased by 26% and 13% respectively, while Newpage's sales grew by 82% and 166% [5] - The company is optimizing its channel structure and enriching its product offerings, with Han Shu's channel structure becoming healthier and its product mix becoming more balanced [5]

Core Viewpoint - The Chinese cosmetics industry is undergoing a significant "ingredient revolution," with recombinant collagen emerging as a core force in reconstructing product value systems. The key question remains whether large molecular recombinant collagen can effectively penetrate the skin barrier to reach its target sites [3][4]. Group 1: Technological Breakthroughs - The "transdermal collagen" technology developed by Kemi, a brand under Furuida Bio Co., has been recognized as reaching an internationally leading level by the China Light Industry Federation [4][20]. - Kemi's technology has achieved a 27.5 times increase in transdermal efficiency, addressing the industry-wide challenge of large molecular penetration [6][10]. - The core issue of collagen efficacy lies in the dilemma of activity versus permeability, with traditional methods reducing molecular size at the cost of biological activity [7][11]. Group 2: Innovative Solutions - Kemi's solution involves a systematic technology called "transdermal collagen," which enhances the penetration ability of large molecular collagen through genetic engineering [8][11]. - The "transmembrane peptide" acts as a "biological engine," enabling large molecular collagen to actively penetrate cell membranes, thus overcoming traditional passive diffusion limitations [8][10]. - The "super glass collagen microsphere" technology ensures stable presence and sustained release of active collagen within the skin, significantly improving penetration rates [10][11]. Group 3: Market Validation - Kemi's flagship product, the "Kemi Recombinant Collagen Anti-Wrinkle Essence," combines the two proprietary delivery technologies, resulting in measurable skincare effects [12][14]. - In just eight months, the transdermal collagen essence achieved sales exceeding 23 million units, topping various e-commerce beauty charts [14][15]. - The brand's marketing strategy focuses on building trust through deep communication and collaboration with authoritative media, enhancing consumer perception of its technological innovations [15][16]. Group 4: Industry Impact and Standards - Kemi has transitioned from a "dark horse" to a "definer" in the industry, actively participating in the formulation of industry standards, including the first group standard for measuring the penetration efficacy of recombinant collagen [20][23]. - The establishment of these standards marks a shift from vague marketing claims to quantifiable scientific parameters, promoting a new phase of verifiable efficacy in the industry [24][25]. - Kemi's approach signifies a broader industry shift from marketing-driven strategies to technology-driven value creation, setting a benchmark for future developments in the cosmetics sector [25].

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Insights - The report highlights the strong performance of domestic brands during the 38 promotional event, with significant sales figures and consumer demand for effective skincare products [23][25] - The report emphasizes the importance of emotional consumption themes and recommends high-quality companies in high-growth sectors [6][30][31] Summary by Sections Retail and Social Services Market Review - The retail and social services indices reported declines of 3.91% and 3.63% respectively during the week of March 2 to March 6, 2026 [5][15] - Year-to-date, the retail index has decreased by 6.82%, while the social services index has increased by 3.01% [15][16] Industry Dynamics - Domestic brands performed well during the 38 promotional event, with leading brands like Proya achieving significant sales [23] - The report notes that the skincare product category is seeing strong demand, particularly for effective and functional products [23][25] Investment Recommendations - Investment focus areas include: - **Gold and Jewelry**: Recommend brands with differentiated product offerings such as Laopuhuang and Chaohongji [6][30] - **Offline Retail**: Highlight companies adapting to trends like Yonghui Supermarket and Aiyingshi [6][30] - **Cosmetics**: Focus on brands that meet emotional value and safety innovation, recommending brands like Maogeping and Proya [6][31] - **Medical Aesthetics**: Suggest companies with differentiated products and expanding chains, such as Meilitiantian Medical Health and Aimeike [6][31] Company Performance Highlights - **Shangmei Co.**: Expected revenue of 9.1-9.2 billion yuan for 2025, with a year-on-year growth of 34.0%-35.4% [27] - **Zhou Dafu**: Achieved a retail value increase of 17.8% year-on-year in Q3 2026 [32] - **Yonghui Supermarket**: Anticipated revenue decline but undergoing significant operational adjustments [32]

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting potential growth despite recent market underperformance [2][3]. Core Insights - The cosmetics and medical beauty sector has underperformed the market, with the Shenwan Beauty Care Index declining by 3.0% from February 27 to March 6, 2026. The Shenwan Cosmetics Index fell by 4.9%, while the Shenwan Personal Care Products Index decreased by 0.7% [3][4]. - Upbeauty Co., Ltd. has exceeded expectations for 2025, forecasting revenue between 9.1 billion and 9.2 billion yuan, representing a year-on-year increase of 34.0%-35.4%. The net profit attributable to shareholders is expected to be between 1.14 billion and 1.16 billion yuan, reflecting a growth of 41.9%-44.4% [9]. - The report emphasizes the importance of Upbeauty’s core anti-aging product line, which is continuously iterating to meet the upgrading trend of domestic anti-aging consumption, thereby enhancing both brand and product strength [9]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the overall market, with significant declines in key indices [3][4]. - The report notes that the Shenwan Cosmetics Index's decline of 4.9% is notably worse than the Shenwan A Index by 2.5 percentage points [4]. Company Highlights - Upbeauty Co., Ltd. is highlighted for its strong performance, with a positive earnings forecast for 2025, driven by its core business and product innovation [9]. - Huaxi Biological (688363.SH) reported a net profit of 291 million yuan for 2025, a year-on-year increase of 67.03%, indicating a successful strategic transformation [3][9]. - Yixian E-commerce reported a revenue of 4.3 billion yuan for 2025, a 26.7% increase year-on-year, marking its first annual Non-GAAP profit since its listing [22]. Market Trends - The report identifies a structural growth phase in the nutrition and health food market, with a market size reaching over 100 billion yuan, significantly outpacing traditional food sectors [11]. - The online DTC channel is recognized as a core growth engine for the industry, with companies like Xizi Health achieving over 98% of their revenue from online sales [11]. Investment Recommendations - The report recommends focusing on companies with strong channel and brand matrices, such as Upbeauty Co., Ltd. and Mao Ge Ping, which are expected to see high GMV growth [3][9]. - It also suggests monitoring companies with improving performance metrics, including Proya, Marubi, and Huaxi Biological, as well as those in the maternal and infant sector like Shengbeila and Kidswant [3].

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Insights - The report highlights the strong performance of domestic brands during the 38 promotional event, with significant sales figures and consumer demand for effective skincare products [23][25] - The report emphasizes the importance of emotional consumption themes and recommends high-quality companies in high-growth sectors [6][30][31] Summary by Sections Retail and Social Services Market Review - The retail and social services indices reported declines of 3.91% and 3.63% respectively during the week of March 2 to March 6, 2026, ranking 25th and 23rd among 31 primary industries [5][15] - Year-to-date, the retail index has decreased by 6.82%, while the social services index has increased by 3.01% [12][15] Industry Dynamics - The 38 promotional event saw domestic brands excel, with significant sales figures reported from live streaming platforms [23][25] - Key brands such as Pechoin and Betainy led in product selection and sales performance during the promotional period [23][24] Investment Recommendations - Investment focus areas include: - Gold and jewelry brands with differentiated product offerings, recommending companies like Laopuhuangjin and Chaohongji [6][30] - Offline retail companies adapting to market changes, recommending Yonghui Supermarket and Aiyingshi [6][30] - Domestic beauty brands that emphasize emotional value and innovative ingredients, recommending Maogeping and Shangmei [6][31] - Medical aesthetics firms with differentiated products, recommending Meilitiantian and Aimeike [6][31] Company Performance Highlights - Shangmei Co. is projected to achieve revenues of 9.1-9.2 billion yuan, a year-on-year increase of 34.0%-35.4%, with net profits expected to reach 1.14-1.16 billion yuan, up 41.9%-44.4% [27][29] - Zhou Dafu reported a retail value increase of 17.8% year-on-year for FY2026Q3, driven by product structure optimization [32]